Arrhythmia
EU ARRHYTHMIA PARTNER
US ARRHYTHMIA PARTNER
An Introduction to Arrhythmia
Advances in the understanding of arrhythmias has improved diagnosis and led to the discovery of new therapies. Large-scale studies into the direct oral anticoagulation treatment paradigm continue to improve patient selection, and technological advances such as hand-held ECG devices and implantable loop recorders have been shown to aid in arrhythmia detection.
Browse the content below where leading experts discuss the latest data in video interviews and short articles from our conference hub, and browse the selection of peer- reviewed articles from our journal portfolio.
Our supporting partners do not constitute an endorsement of the content on this page.
Physician burnout is at a critical point. In this episode, Nicky speaks with Dr Alfred Atanda about why so many physicians are burning out and what can be done to change the trend. From personal experience to system-wide solutions, Dr Atanda shares valuable insights on improving physician well-being and building a more effective healthcare culture.
What if your medical degree could launch more than a clinical career? In this candid and compelling read, Dr Jon Edelson shares his lessons for early-career clinicians ready to think beyond the bedside and explore the business of medicine.
On April 25, 2025, the FDA approved the OmniaSecure defibrillation lead, a 1.6 mm, catheter-delivered, lumenless lead for right ventricular implantation. The small-diameter lead is designed to connect to an implantable defibrillator and treat ventricular tachyarrhythmias, ventricular fibrillation, and bradyarrhythmias, with LEADR trial data showing high implant success, safety, and electrical performance.
In this Q&A, he shares insights into his career journey, the experiences that shaped his path and what excites him most about the future of cardiology.
It is with pride and gratitude that we reflect on the remarkable 10-year journey of European Journal of Arrhythmia & Electrophysiology. With the vital contributions of all of our esteemed authors, reviewers and editorial board members, the journal has served ...
Postural tachycardia syndrome (PoTS) is a chronic condition, predominately affecting women between the ages of 15 and 50, and prevalence is estimated to be 0.2%.1,2 It is characterised by an abnormal response by the autonomic nervous system to changes in posture causing lightheadedness ...
As 2024 draws to a close, we’re celebrating a wonderful year of content. From insightful expert Q&As and peer-reviewed articles to conference highlights and a wealth of medical education, it’s been a year filled with content that we hope has been useful to our audience. We’ve had the privilege of connecting with leading experts and working alongside medical societies to support the cardiology community with high-quality, easily accessible content.
Visionary Voices: Season 1, Episode 7 Join us in this episode as Trudie Lobban, Founder and Trustee of Arrhythmia Alliance, discusses the remarkable work of Pace4Life. This innovative charity repurposes cardiac electronic devices, delivering critical heart care to communities in low- ...
touchCARDIO is delighted to announce that Heart International has received an impressive new Impact Factor of 1.9 in the 2024 Journal Citation Reports (JCR). This achievement marks a notable increase from last year’s Impact Factor of 0.2 and highlights the journal’s growing influence in the cardiology field.
A recent study has uncovered a significant association between residential exposure to transportation noise and the risk of developing atrial fibrillation (AF). The study, published in The Lancet Regional Health - Europe reveals that individuals exposed to elevated levels of road traffic noise face a 2% increase in the risk of AF for every 10-decibel rise in noise exposure. Notably, this risk was amplified among women and those with higher body mass indices, underscoring the need for heightened awareness of environmental health risks.
A recent study by Ryan Woltzand colleagues from the Howard Hughes Medical Institute (CA, USA) in PNAS reveals that phosphatidylinositol 4,5-bisphosphate (PIP2) plays a critical role in regulating small-conductance Ca²+-activated K⁺ (SK2) channels by disrupting a key salt bridge that modulates channel activation. This discovery not only enhances our understanding of ion channel dynamics but also holds significant promise for the development of targeted therapies for atrial fibrillation (AF).
We’re looking forward to the Heart Rhythm Congress, which is taking place in Birmingham, UK between 6-8 October 2024. Promising attendees an opportunity to explore the largest heart rhythm conference in the UK. We are excited to provide independent, expert ...
The ESC Congress is a key event in our conference calendar, and this year, London will welcome thousands of cardiologists and allied healthcare professionals. Together, they will work to transform patient care and advance the field through cutting-edge research, pioneering technologies, and collaborative initiatives.
Catheter ablation (CA) is an invasive adjunctive therapeutic option for atrial and ventricular arrhythmias, in uncontrolled cases, following optimal medical therapy.1,2 The validation of 3D mapping and its implementation into clinical usage has been a remarkable achievement in the field ...
Welcome to the latest issue of the European Journal of Arrhythmia & Electrophysiology, the official journal of the Arrhythmia Alliance. We are honoured to present a series of compelling articles that reflect cutting-edge developments and diverse perspectives in this ever-evolving ...
Ventricular tachycardia (VT) ablation presents a challenging and growing area of focus in the realm of complex ablation, with promises of improved patient’s quality of life and clinical outcomes.1,2 Classic approaches to VT ablation centered on arrhythmia induction and ...
For decades, right ventricular pacing (RVP) has been the leading pacing technique and has been proven to be effective in treating patients with symptomatic bradycardia. However, dyssynchrony caused by non-physiological ventricular activation results in pacing-induced cardiomyopathy occurs in approximately 15% of ...
Log into your Touch Account
Earn and track your CME credits on the go, save articles for later, and follow the latest congress coverage.
Sign up with an Email
Or use a .
This Functionality is for
Members Only
Explore the latest in medical education and stay current in your field. Create a free account to track your learning.
